- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03823183
Multi-domain Versus Uni-Domain Training on Executive Control and Memory Functions of Older Adults (VIBAL)
Protocol for a Randomized Controlled Trial With Active Control on the Effects of Combined Physical and Cognitive Training Versus Cognitive and Physical Training Separately on Executive Control and Memory Functions of Older Adults
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28040
- Department of Basic Psychology II (UNED)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
No current intensive sports or physical activity practice. No current use of brain-training video games
Exclusion Criteria:
Dementia. Mild Cognitive Impairment. A neurological or major psychiatric disorder. Significant heart illness. Lung disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Multi-domain training
Group that receives cognitive training and physical training
|
Group-based cognitive training on iPads with commercially available video games (Lumosity) designed to enhance executive control, memory functions and processing speed.
Difficulty will be automatically adjusted to the performance level of the participant.
Participants will train for 40 min 2 days/wk over 3 months.
Group-based fitness program (senior-friendly adaption of BodyAttack) that combines aerobic, strength and coordination training to a music soundtrack.
Participants will train for 40 min, 2 days/wk over 3 months.
|
Experimental: Cognitive training
Group that receives cognitive training and physical control activity
|
Group-based cognitive training on iPads with commercially available video games (Lumosity) designed to enhance executive control, memory functions and processing speed.
Difficulty will be automatically adjusted to the performance level of the participant.
Participants will train for 40 min 2 days/wk over 3 months.
Group-based exercises program (based on relaxation and stretching) for 40 min, 2 days/wk over 3 months.
|
Experimental: Physical activity
Group that receives control cognitive activity and physical training
|
Group-based fitness program (senior-friendly adaption of BodyAttack) that combines aerobic, strength and coordination training to a music soundtrack.
Participants will train for 40 min, 2 days/wk over 3 months.
Group-based cognitive control activity consisting of playing on iPads non-cognitively demanding video games during 40 min 2 days/wk over 3 months and exercises based on relaxation and stretching for 40 min, 2 days/wk over 3 months.
|
Active Comparator: Active control
Group that receives cognitive control activity and physical control activity
|
Group-based exercises program (based on relaxation and stretching) for 40 min, 2 days/wk over 3 months.
Group-based cognitive control activity consisting of playing on iPads non-cognitively demanding video games during 40 min 2 days/wk over 3 months and exercises based on relaxation and stretching for 40 min, 2 days/wk over 3 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Executive functions assessed with Memory-based Task Switching
Time Frame: Change from Baseline in Memory-based Task Switching to 3 and 6 months
|
Reaction time (RT) of correct responses in Memory-based Task Switching
|
Change from Baseline in Memory-based Task Switching to 3 and 6 months
|
Executive functions assessed with Memory-based Task Switching
Time Frame: Change from Baseline in Memory-based Task Switching to 3 and 6 months
|
Performance in the Memory-base Task Switching: Neurophysiological parameter-Event-related potentials (ERPs) in the Memory-Based Task Switching
|
Change from Baseline in Memory-based Task Switching to 3 and 6 months
|
Attention assessed with Trail Making Test A+B
Time Frame: Change from Baseline in Trail Making Test to 3 and 6 months
|
Performance in Trail Making Test A+B score
|
Change from Baseline in Trail Making Test to 3 and 6 months
|
Inhibition assessed with Stroop Task
Time Frame: Change from Baseline in Stroop Task to 3 and 6 months
|
Reaction time (RT) of correct responses in the Stroop Task
|
Change from Baseline in Stroop Task to 3 and 6 months
|
Working memory assessed with the N-back Task
Time Frame: Change from Baseline in the N-Back Task to 3 and 6 months
|
Hits-False Alarms in the N-back Task
|
Change from Baseline in the N-Back Task to 3 and 6 months
|
Immediate visual memory assessed with Visual Memory Face I (Weschler Memory Scale)
Time Frame: Change from Baseline in Face I to 3 and 6 months
|
Units on the Scale: scale range (minimum score = 0 and maximum score = 48).
|
Change from Baseline in Face I to 3 and 6 months
|
Differed visual memory assessed with Visual Memory Face II (Weschler Memory Scale)
Time Frame: Change from Baseline in Face II to 3 and 6 months
|
Units on the Scale: scale range (minimum score = 0 and maximum score = 48). With data from Visual Memory Face I (inmediate recognition) and Visual Memory Face II (differed recognition) we compute the percentage of memory retention = Visual Memory Face II / Visual Memory Face I X 100 |
Change from Baseline in Face II to 3 and 6 months
|
Immediate verbal memory assessed with Pair-Words I (Weschler Memory Scale)
Time Frame: Change from Baseline in Pair-Words I to 3 and 6 months
|
Units on the Scale: scale range for Recall (minimum score = 0 and maximum score = 32).
|
Change from Baseline in Pair-Words I to 3 and 6 months
|
Differed verbal memory assessed with Pair-Words II (Weschler Memory Scale)
Time Frame: Change from Baseline in Pair-Words II to 3 and 6 months
|
Units on the Scale: scale range for Recall (minimum score = 0 and maximum score = 8). scale range for Recognition (minimum score =0 and maximum score = 24) Recall. With data from Pair-Words I (inmediate recognition) and Pair-Words II (differed recognition) we compute the percentage of memory retention = Pair-Words II / Pair-Word I X 100 |
Change from Baseline in Pair-Words II to 3 and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Emotional and affective wellbeing assessed with Positive and Negative Affect Schedule (PANAS)
Time Frame: Change from Baseline in PANAS to 3 and 6 months
|
Units on the Scale: 20 items Each item is evaluated between 0 (nothing) and 5 (many).
Positive emotions are assessed with items: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19.
Negative emotions are assessed with items: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20.
|
Change from Baseline in PANAS to 3 and 6 months
|
Emotional and affective wellbeing assessed with The Life Satisfaction Index (LSI): 20 items Each item is assessed using two-point agree/disagree score rated items 0 for a response indicating dissatisfaction and 1 for satisfaction.
Time Frame: Change from Baseline in LSI to 3 and 6 months
|
Units on the Scale: 20 items A two-point agree/disagree score rated items 0 for a response indicating dissatisfaction and 1 for satisfaction.
|
Change from Baseline in LSI to 3 and 6 months
|
Cardio-respiratory capacity assessed with the 6 Minutes Walk Test
Time Frame: Change from Baseline in 6 Minutes Walk Test to 3 and 6 months
|
Physiological parameter
|
Change from Baseline in 6 Minutes Walk Test to 3 and 6 months
|
Physical dimension assessed with The Short Physical Performance Battery (SPPB)
Time Frame: Change from Baseline in SPPB to 3 and 6 months
|
Units on the Scale
|
Change from Baseline in SPPB to 3 and 6 months
|
Demographic interview and medical history
Time Frame: Baseline
|
Respond to questions related to demographics and medical history
|
Baseline
|
General cognitive state assessed with Mini Mental State Examination (MMSE)
Time Frame: Baseline
|
Units on the test: scale range (minimum score = 0 and maximum score = 30). Values between 27 and 30 points are considered as "appropriate cognitive state". Values between 24 and 26 points are considered as "possible mild cognitive impairment" Values between 0 and 23 points are considered as "possible dementia". This test is a screening test and it is not adequate to diagnose. In this protocol participants with scores under 27 will be excluded from the study. |
Baseline
|
General depression state assessed with Yesavage Abbreviate Questionnaire. (GDS)
Time Frame: Baseline
|
Units on the test: scale range (minimum score = 0 and maximum score = 15).
Values between 0 and 5 points are considered as "no depression".
Values between 5 and 10 points are considered as "mild depression" Values between 10 and 15 points are considered as "severe depression".
This test is a screening test and it is not adequate to diagnose.
In this protocol participants with scores greater than 5 will be excluded from the study.
|
Baseline
|
Collaborators and Investigators
Investigators
- Principal Investigator: Soledad Ballesteros, PhD, UNED
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PSI2016-80377-R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Memory Functions
-
Prof. Dominique de Quervain, MDClinical Trial Unit, University Hospital Basel, SwitzerlandCompletedMemory FunctionsSwitzerland
-
Prof. Dominique de Quervain, MDClinical Trial Unit, University Hospital Basel, SwitzerlandCompletedMemory FunctionsSwitzerland
-
Zonguldak Bulent Ecevit UniversityCompleted
-
Yuzuncu Yıl UniversityCompletedAnesthesia | Geriatric | Liver Functions | Kidney FunctionsTurkey
-
Maharishi Markendeswar University (Deemed to be...RecruitingCognitive FunctionsIndia
-
Eastern Mediterranean UniversityRecruitingGastrointestinal FunctionsCyprus
-
Gazi UniversityCompletedPostoperative Cognitive FunctionsTurkey
-
European University Miguel de CervantesCentro Doctor Villacián, Valladolid, SpainRecruiting
-
NovaSightNot yet recruiting
-
National Cancer Institute, EgyptEnrolling by invitation
Clinical Trials on Cognitive training
-
Science and Research Centre KoperAlbert Einstein College of Medicine; University of Primorska; Vrije Universiteit...CompletedEffects of Cognitive Intervention on Cognition, Mobility and Brain Electrocortical Activity (GIBKOP)Cognitive Impairment | Aging | Cognitive Decline | Motor Coordination or FunctionSlovenia
-
Hospital de Clinicas de Porto AlegreYale UniversityUnknownAttention-deficit/Hyperactivity Disorder.Brazil
-
Universidade Federal do Rio de JaneiroUnknown
-
Chang Gung Memorial HospitalRecruitingVirtual Reality | Community-dwelling ElderlyTaiwan
-
Xuanwu Hospital, BeijingRecruitingMild Cognitive ImpairmentChina
-
Fundació Sant Joan de DéuCompletedIndication for Modification of Patient Cognitive StatusSpain
-
Chang Gung Memorial HospitalRecruitingMCI | SCD | Virtual RealityTaiwan
-
University of California, San FranciscoCompletedSchizophrenia | PsychosisUnited States
-
Chiang Mai UniversityCompletedMild Cognitive ImpairmentThailand
-
VA Office of Research and DevelopmentCompleted